Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-052466

Chief Financial Officer acquired 80,366 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Horn Howard · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-09 Grant or award : show line 1 in the form +80,366 80,336 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-10-09 Grant or award : show line 2 in the form Stock Option (Right to Buy) +140,469 140,469 D
Loading xslF345X05/doc4.xml…